News and Media

Latest News Release

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...


Press Releases

Cardinal Health to Acquire Medical Analytics Firm, MedMined
DUBLIN, Ohio, July 12, 2006 -- Cardinal Health, the leading provider of products and services supporting the health-care industry, today announced plans to acquire privately held MedMined, Inc., a leader in technology and services that identify and prevent hospital-acquired infections.
The acquisition will immediately extend Cardinal Health’s portfolio of patient safety solutions in the areas of hospital-acquired infections and antimicrobial management. Terms of the agreement were not disclosed.
Reducing Hospital Infections
Hospital-acquired infections directly affect patient outcomes and are estimated to cost the health-care industry billions of dollars each year. Current estimates are that one out of every 20 patients gets an infection as a result of hospitalization, leading to higher costs, longer hospital stays and a greater risk of death.
Using patented data-mining methods to analyze hospital records, MedMined helps identify specific opportunities to manage infections and change processes to prevent future infections. The data may also be used to efficiently report infection rates, enabling hospitals to provide the public with meaningful information from which to make comparisons.  Many hospitals using MedMined's Data Mining Surveillance® service have achieved a significant financial return in the first year of use by improving practices, reducing infection rates and lowering non-variable reimbursement costs.
MedMined services are currently used in approximately 185 hospitals in more than 25 states and are made available to local hospitals for quality initiatives through Blue Cross Blue Shield in six states:  Alabama, California, Pennsylvania, New Jersey, New York and Texas. 
“Hospitals have a long history of striving to prevent infections and MedMined’s techniques now provide them with information that complement their safety initiatives and support measurable improvements,” said David Schlotterbeck, chief executive officer of Pharmaceutical and Medical Products for Cardinal Health.

“MedMined advances Cardinal Health’s long-standing commitment to help our hospital partners improve safety by reducing variations in clinical practices.  There are significant opportunities to extend MedMined’s data-mining and technology-based services to the medication management solutions we offer today with our Alaris and Pyxis products.”
Stephen Brossette, president of MedMined added, “We are very excited to join one of the world’s premier health-care companies.  Cardinal Health shares our vision for patient safety and already has leading medication safety and outcomes measurement offerings that fit well with our hospital-acquired infection solutions.  Given Cardinal Health’s breadth and depth of knowledge and experience in managing medications in hospitals, we expect to find additional opportunities to apply our patented data-mining methods to deliver value to customers.”
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $75 billion, global company serving the health-care industry with a broad portfolio of products and services. Through its diverse offering, Cardinal Health delivers integrated health-care solutions that help customers reduce their costs, improve efficiency and deliver better care to patients. The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents. More information about the company may be found at
More Company News

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...


Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, highlighting the company's work toward building a healthier, more equitable future....


Revenue increased 12% to $57.4 billion GAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS...


Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

View all company news »